肝硬化门静脉高压症的肝移植治疗
Liver transplantation in treatment of cirrhotic portal hypertension
李涛, 陈皓 . 肝硬化门静脉高压症的肝移植治疗[J]. 外科理论与实践, 2021 , 26(03) : 189 -194 . DOI: 10.16139/j.1007-9610.2021.03.002
| [1] | de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis[J]. Clin Liver Dis, 2001, 5(3):645-663. |
| [2] | Hackl C, Schlitt HJ, Renner P, et al. Liver surgery in cirrhosis and portal hypertension[J]. World J Gastroenterol, 2016, 22(9):2725-2735. |
| [3] | Bosch J, Iwakiri Y. The portal hypertension syndrome: etiology, classification, relevance, and animal models[J]. Hepatol Int, 2018, 12(Suppl 1):1-10. |
| [4] | Garcia-Tsao G. The use of nonselective beta blockers for treatment of portal hypertension[J]. Gastroenterol Hepatol, 2017, 13(10):617-619. |
| [5] | Kim WR, Lake JR, Smith JM, et al. OPTN/SRTR 2015 annual data report: liver[J]. Am J Transplant, 2017, 17(Suppl 1):174-251. |
| [6] | Iwatsuki S, Starzl TE, Todo S, et al. Liver transplantation in the treatment of bleeding esophageal varices[J]. Surgery, 1988, 104(4):697-705. |
| [7] | Wood RP, Shaw BW Jr, Rikkers LF. Liver transplantation for variceal hemorrhage[J]. Surg Clin North Am, 1990, 70(2):449-461. |
| [8] | Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers[J]. Gastroenterology, 2003, 124(1):91-96. |
| [9] | Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant wai-ting list[J]. N Engl J Med, 2008, 359(10):1018-1026. |
| [10] | Mahmud N. Selection for liver transplantation: indications and evaluation[J]. Curr Hepatol Rep, 2020:1-10. |
| [11] | Martin P, Dimartini A, Feng S, et al. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation[J]. Hepatology, 2014, 59(3):1144-1165. |
| [12] | Zipprich A, Garcia-Tsao G, Rogowski S, et al. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis[J]. Liver Int, 2012, 32(9):1407-1414. |
| [13] | D'amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review[J]. Hepatology, 1995, 22(1):332-354. |
| [14] | Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis[J]. Am J Gastroenterol, 2007, 102(9):2086-2102. |
| [15] | Zocco MA, di Stasio E, de Cristofaro R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development[J]. J Hepatol, 2009, 51(4):682-689. |
| [16] | 徐骁, 郭海军, 李望遥. 肝移植时代门静脉高压症的治疗选择[J]. 中华消化外科杂志, 2018, 17(10):992-996. |
| [17] | Simonetto DA, Liu M, Kamath PS. Portal hypertension and related complications: diagnosis and management[J]. Mayo Clin Proc, 2019, 94(4):714-726. |
| [18] | Snyder P, Ali R, Poles M, et al. Portal hypertensive gastropathy with a focus on management[J]. Expert Rev Gastroenterol Hepatol, 2015, 9(9):1207-1216. |
| [19] | Akatsu T, Yoshida M, Kawachi S, et al. Consequences of living-donor liver transplantation for upper gastrointestinal lesions: high incidence of reflux esophagitis[J]. Dig Dis Sci, 2006, 51(11):2018-2022. |
| [20] | Wijdicks EF. Hepatic encephalopathy[J]. N Engl J Med, 2016, 375(17):1660-1670. |
| [21] | Fichet J, Mercier E, Genée O, et al. Prognosis and 1-year mortality of intensive care unit patients with severe he-patic encephalopathy[J]. J Crit Care, 2009, 24(3):364-370. |
| [22] | Lucidi C, Ginanni Corradini S, Abraldes JG, et al. He-patic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: evidence by means of 2 independent cohorts[J]. Liver Transpl, 2016, 22(10):1333-1342. |
| [23] | Bernal W, Hyyrylainen A, Gera A, et al. Lessons from look-back in acute liver failure? a single centre expe-rience of 3300 patients[J]. J Hepatol, 2013, 59(1):74-80. |
| [24] | Hopp AE, Dirks M, Petrusch C, et al. Hepatic encephalopathy is reversible in the long term after liver transplantation[J]. Liver Transpl, 2019, 25(11):1661-1672. |
| [25] | Garbuzenko DV, Arefyev NO. Current approaches to the management of patients with cirrhotic ascites[J]. World J Gastroenterol, 2019, 25(28):3738-3752. |
| [26] | Adebayo D, Neong SF, Wong F. Refractory ascites in li-ver cirrhosis[J]. Am J Gastroenterol, 2019, 114(1):40-47. |
| [27] | Arroyo V, Gines P, Gerbes AL, et al. Definition and dia-gnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club[J]. Hepatology, 1996, 23(1):164-176. |
| [28] | Planas R, Montoliu S, Ballesté B, et al. Natural history of patients hospitalized for management of cirrhotic ascites[J]. Clin Gastroenterol Hepatol, 2006, 4(11):1385-1394. |
| [29] | Gines P, Cardenas A, Arroyo V, et al. Management of cirrhosis and ascites[J]. N Engl J Med, 2004, 350(16):1646-1654. |
| [30] | Moreau R, Delegue P, Pessione F, et al. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites[J]. Liver Int, 2004, 24(5):457-464. |
| [31] | Somsouk M, Kornfield R, Vittinghoff E, et al. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk[J]. Liver Transpl, 2011, 17(2):129-136. |
| [32] | Adebayo D, Neong SF, Wong F. Ascites and hepatorenal syndrome[J]. Clin Liver Dis, 2019, 23(4):659-682. |
| [33] | Ng CK, Chan MH, Tai MH, et al. Hepatorenal syndrome[J]. Clin Biochem Rev, 2007, 28(1):11-17. |
| [34] | Terra C, Mattos ÂZ, Pereira G, et al. Recommendations of the Brazilian Society of Hepatology for the management of acute kidney injury in patients with cirrhosis[J]. Arq Gastroenterol, 2018, 55(3):314-320. |
| [35] | Mindikoglu AL, Pappas SC. New developments in hepatorenal syndrome[J]. Clin Gastroenterol Hepatol, 2018, 16(2):162-177. |
| [36] | Alessandria C, Ozdogan O, Guevara M, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation[J]. Hepatology, 2005, 41(6):1282-1289. |
| [37] | Utako P, Emyoo T, Anothaisintawee T, et al. Clinical outcomes after liver transplantation for hepatorenal syndrome: a systematic review and meta-analysis[J]. Biomed Res Int, 2018, 2018:5362810. |
| [38] | Wong F, Leung W, Al Beshir M, et al. Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation[J]. Liver Transpl, 2015, 21(3):300-307. |
| [39] | Francoz C, Durand F, Kahn JA, et al. Hepatorenal syndrome[J]. Clin J Am Soc Nephrol, 2019, 14(5):774-781. |
| [40] | Velez JCQ, Therapondos G, Juncos LA. Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis[J]. Nat Rev Nephrol, 2020, 16(3):137-155. |
| [41] | Razavi-Khorasani N, Moazzami B, Dooghaie Moghadam A, et al. Pulmonary complications in candidates for liver transplantation[J]. Middle East J Dig Dis, 2020, 12(3):145-153. |
| [42] | Goldberg DS, Krok K, Batra S, et al. Impact of the he-patopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of the UNOS database[J]. Gastroenterology, 2014, 146(5):1256-1265. |
| [43] | Cywinski JB, Makarova N, Arney A, et al. Resources utilization after liver transplantation in patients with and without hepatopulmonary syndrome: Cleveland Clinic experience[J]. Transplant Direct, 2020, 6(4):e545. |
| [44] | Schenk P, Schöniger-Hekele M, Fuhrmann V, et al. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis[J]. Gastroenterology, 2003, 125(4):1042-1052. |
| [45] | Gupta S, Krowka MJ. Hepatopulmonary syndrome[J]. CMAJ, 2018, 190(8):E223. |
| [46] | Iyer VN, Swanson KL, Cartin-Ceba R, et al. Hepatopulmonary syndrome: favorable outcomes in the MELD exception era[J]. Hepatology, 2013, 57(6):2427-2435. |
| [47] | Krowka MJ, Swanson KL, Frantz RP, et al. Portopulmonary hypertension: results from a 10-year screening algorithm[J]. Hepatology, 2006, 44(6):1502-1510. |
| [48] | Cartin-Ceba R, Krowka MJ. Pulmonary complications of portal hypertension[J]. Clin Liver Dis, 2019, 23(4):683-711. |
| [49] | Swanson KL, Wiesner RH, Nyberg SL, et al. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups[J]. Am J Transplant, 2008, 8(11):2445-2453. |
| [50] | Krowka MJ, Plevak DJ, Findlay JY, et al. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation[J]. Liver Transpl, 2000, 6(4):443-450. |
| [51] | Krowka MJ, Fallon MB, Kawut SM, et al. International Liver Transplant Society Practice Guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension[J]. Transplantation, 2016, 100(7):1440-1452. |
| [52] | Raevens S, Colle I, Reyntjens K, et al. Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values[J]. Liver Transpl, 2013, 19(6):602-610. |
| [53] | Lasch HM, Fried MW, Zacks SL, et al. Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome[J]. Liver Transpl, 2001, 7(2):147-149. |
| [54] | Huang L, Yu QS, Zhang Q, et al. Transjugular intrahe-patic portosystemic shunt versus surgical shunting in the management of portal hypertension[J]. Chin Med J (Engl), 2015, 128(6):826-834. |
| [55] | Henderson JM. Surgical treatment of portal hypertension[J]. Baillieres Best Pract Res Clin Gastroenterol, 2000, 14(6):911-925. |
| [56] | Chen H, Turon F, Hernández-Gea V, et al. Nontumoral portal vein thrombosis in patients awaiting liver transplantation[J]. Liver Transpl, 2016, 22(3):352-365. |
| [57] | Violi F, Corazza GR, Caldwell SH, et al. Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry[J]. Intern Emerg Med, 2016, 11(8):1059-1066. |
| [58] | Stine JG, Shah PM, Cornella SL, et al. Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: a meta-analysis[J]. World J Hepatol, 2015, 7(27):2774-2780. |
| [59] | D'amico G, de Franchis R. Upper digestive bleeding in cirrhosis. post-therapeutic outcome and prognostic indicators[J]. Hepatology, 2003, 38(3):599-612. |
| [60] | Rugivarodom M, Charatcharoenwitthaya P. Nontumoral portal vein thrombosis: a challenging consequence of li-ver cirrhosis[J]. J Clin Transl Hepatol, 2020, 8(4):432-444. |
| [61] | Zanetto A, Rodriguez-Kastro KI, Germani G, et al. Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis[J]. Transpl Int, 2018, 31(12):1318-1329. |
| [62] | Vianna RM, Mangus RS, Kubal C, et al. Multivisceral transplantation for diffuse portomesenteric thrombosis[J]. Ann Surg, 2012, 255(6):1144-1150. |
/
| 〈 |
|
〉 |
